Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12611000676910
Ethics application status
Approved
Date submitted
3/07/2011
Date registered
5/07/2011
Date last updated
11/07/2011
Type of registration
Retrospectively registered

Titles & IDs
Public title
2 hourly versus 3 hourly feeding in premature infants: A randomised control trial
Scientific title
The effect of 2 hourly versus 3 hourly feeding on duration to full feeding and body mass in premature infants
Secondary ID [1] 252960 0
NA
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Feeding premature infant 268208 0
Condition category
Condition code
Reproductive Health and Childbirth 258659 258659 0 0
Complications of newborn

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Premature infants will be given 3 hourly feeding
1. All infants will be given IV dextrose 10% or TPN at 65 to 80mls per kg per day at the first hour of life
2. Enteral feeding will be started before 96 hours of life
3. All infants will be fed with expressed breast milk
4. If mother's breast milk is insufficient preterm formula is added
5. Feeding will be started at 10 to 20mls pe r kg per day
6. Advancement of the feeding at 10 to 20mls per kg per day 7. All the infants will be fed via oral gastric tube
8. Oral gastric tube placement by staff nurse using pre established technique
9. Feeding will be given over 15 to 30 minutes with gravity depending on the volume of the milk
10. Gastric residual will be checked immediately before feeding unless requested by the managing team of not doing so.
11. If any clinical signs of enteral intolerance and/or severe medical instability were noted, then the feeding volume will be reduced or the feedings will temporarily withheld according to clinical routines.
12. TPN will be started at least before 24 hours of life, the volume is increase 15mls/kg/day to a target volume of 140 to 160 ml/kg/day
13. When enteral feedings reached 100mls/kg of the total target volume, TPN will be discontinued.
14. Pre feeding dextrostic will be monitore d every shift (8 hourly) for 48hour to observe episode of hypoglycaemia in the infants
15. Urine ketone also will be monitored every day for 48 hour once the IVD is off.
Intervention code [1] 257487 0
Treatment: Other
Comparator / control treatment
Premature infants who are on 2 hourly feeding. The control group will go through the similar feeding protocol as the intervention group except that the feeding schedule where they will be given 2 hourly feeding while the intervention group will get 3 hourly feeding.
Feeding Protocol

1. All infants will be given IV dextrose 10% or TPN at 65 to 80mls per kg per day at the first hour of life
2. Enteral feeding will be started before 96 hours of life
3. All infants will be fed with expressed breast milk
4. If mother's breast milk is insufficient preterm formula is added
5. Feeding will be started at 10 to 20mls pe r kg per day
6. Advancement of the feeding at 10 to 20mls per kg per day
7. All the infants will be fed via oral gastric tube
8. Oral gastric tube placement by staff nurse using pre established technique
9. Feeding will be given over 15 to 30 minutes with gravity depending on the volume of the milk
10. Gastric residual will be checked immediately before feeding unless requested by the managing team of not doing so.
11. If any clinical signs of enteral intolerance and/or severe medical instability were noted, then the feeding volume will be reduced or the feedings will temporarily withheld according to clinical routines.
12. TPN will be started at least before 24 hours of life, the volume is increase 15mls/kg/day to a target volume of 140 to 160 ml/kg/day
13. When enteral feedings reached 100mls/kg of the total target volume, TPN will be discontinued.
14. Pre feeding dextrostic will be monitore d every shift (8 hourly) for 48hour to observe episode of hypoglycaemia in the infants
15. Urine ketone also will be monitored every day for 48 hour once the IVD is off.
Control group
Active

Outcomes
Primary outcome [1] 269110 0
Day of achieving full feeding
Timepoint [1] 269110 0
Day where the infants able to tolerate 100ml/kg/day of oral feeding
Primary outcome [2] 269111 0
Day of regaining the birth weight
Timepoint [2] 269111 0
Day where the infants get back their birth weight where the infant will be weight every other day until achieving the birth weight
Secondary outcome [1] 276952 0
Secondary outcome 1: Episode of hypoglycaemia after achieving full feeding and TPN discontinued
Timepoint [1] 276952 0
Timepoint: Dextrostix checked every 8 hourly for 48 hours after TPN discontinued

Eligibility
Key inclusion criteria
Premature infants of 34 weeks gestation and below
The birth weight of 1000gram to 1800gram
Minimum age
No limit
Maximum age
96 Hours
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Congenital Major Malformation include chromosomal abnormalities
2. Severe asphyxia
3. Congenital GIT abnormality such as esophageal atresia, TOF

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
1. All infants who fulfilled the inclusion criteria will be enrolled in this study.
2. Allocation sequence is generated independently by the person who has no role in the recruitment, treatment or assessment of the patient.
3.Concealment of allocation will be ensured using opaque sealed envelopes containing the choice of feeding schedule.
4. No blinding (impossible)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Block randomisation
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 3000 0
Malaysia
State/province [1] 3000 0

Funding & Sponsors
Funding source category [1] 267360 0
University
Name [1] 267360 0
Short Term Grant, School Of Medical Sciences, Universiti Sains Malaysia
Country [1] 267360 0
Malaysia
Primary sponsor type
University
Name
Short Term Grant, School Of Medical Sciences, Universiti Sains Malaysia
Address
School Of Medical Sciences, Universiti Sains Malaysia,
Kubang Kerian, 16150,
Kelantan
Country
Malaysia
Secondary sponsor category [1] 257126 0
None
Name [1] 257126 0
Address [1] 257126 0
Country [1] 257126 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 269341 0
Research Ethics Committee (Human)
Ethics committee address [1] 269341 0
Ethics committee country [1] 269341 0
Malaysia
Date submitted for ethics approval [1] 269341 0
Approval date [1] 269341 0
26/08/2010
Ethics approval number [1] 269341 0
229.3.(01)
Ethics committee name [2] 269342 0
National Medical Research Register,
Ethics committee address [2] 269342 0
Ethics committee country [2] 269342 0
Malaysia
Date submitted for ethics approval [2] 269342 0
Approval date [2] 269342 0
11/04/2011
Ethics approval number [2] 269342 0
NMRR-10-56-5166

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 31835 0
Address 31835 0
Country 31835 0
Phone 31835 0
Fax 31835 0
Email 31835 0
Contact person for public queries
Name 15082 0
Dr Nor Rosidah Ibrahim
Address 15082 0
Department of Paediatric, School of Medical Science, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia.
Country 15082 0
Malaysia
Phone 15082 0
Tel: +6019 9176902
Fax 15082 0
Fax:+609 7647642
Email 15082 0
nrosidah@kb.usm.my
Contact person for scientific queries
Name 6010 0
Dr Nor Rosidah Ibrahim
Address 6010 0
Department of Paediatric, School of Medical Science, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia.
Country 6010 0
Maldives
Phone 6010 0
+6019 9176902
Fax 6010 0
+609 7647642
Email 6010 0
nrosidah@kb.usm.my

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.